Position in SRPT
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$9,994,846
-$452,102 QoQ
Shares Held
459,322
-5.4% QoQ
Ownership
0.435%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
13 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Derivatives in SRPT
reported options exposure · as of Mar 31, 2026CallValue
$1,414,400
CallShares
65,000
PutValue
$411,264
PutShares
18,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026CAPITAL FUND MANAGEMENT S.A. holds $292,594,996 across 34 Biotechnology names. SRPT ranks #9 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
122,934 | $54,894,948 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
140,109 | $46,357,864 | |
| 3 | INCY |
Incyte Corp
|
312,021 | $29,367,416 | |
| 4 | MRNA |
Moderna, Inc.
|
569,930 | $28,952,444 | |
| 5 | EXEL |
Exelixis, Inc.
|
479,693 | $20,574,032 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
174,378 | $11,270,050 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
142,201 | $10,677,873 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
181,065 | $10,228,361 |
All Filings in SRPT
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,414,400 | 65,000 | Call | Sole | 2026-05-14 | |
| 2026-03-31 | $9,994,846 | 459,322 | Shares | Sole | 2026-05-14 | |
| 2026-03-31 | $411,264 | 18,900 | Put | Sole | 2026-05-14 | |
| 2025-12-31 | $3,292,560 | 153,000 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $2,425,304 | 112,700 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $10,446,948 | 485,453 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,626,501 | 136,300 | Put | Sole | 2025-11-13 | |
| 2025-09-30 | $15,031,640 | 780,054 | Shares | Sole | 2025-11-13 | |
| 2025-09-30 | $4,437,881 | 230,300 | Call | Sole | 2025-11-13 | |
| 2025-06-30 | $762,660 | 44,600 | Put | Sole | 2025-08-13 | |
| 2025-06-30 | $8,802,139 | 514,745 | Shares | Sole | 2025-08-13 | |
| 2025-06-30 | $1,058,490 | 61,900 | Call | Sole | 2025-08-13 | |
| 2025-03-31 | $12,772,743 | 200,137 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $21,125,654 | 173,745 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $25,495,793 | 204,146 | Shares | Sole | 2024-11-13 | |
| 2024-03-31 | $5,162,994 | 39,881 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,299,365 | 75,696 | Shares | Sole | 2024-02-14 | |
| 2022-06-30 | $1,126,498 | 15,028 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,803,179 | 35,883 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,567,950 | 17,412 | Shares | Sole | 2022-02-10 | |
| 2020-03-31 | $970,667 | 9,923 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||